Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Alliance for Clinical Trials in Oncology
Related studies linked through entity extraction aliases.
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
- Status
- RECRUITING
- Phase
- NA
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Status
- RECRUITING
- Phase
- PHASE3
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
- Status
- RECRUITING
- Phase
- PHASE3
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial
- Status
- SUSPENDED
- Phase
- PHASE3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- Status
- RECRUITING
- Phase
- PHASE3
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE2
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
- Status
- RECRUITING
- Phase
- PHASE3